of the major economies contributing to the growth of the market over the forecast period. The key factor that drives the growth of the European diabetes care drugs industry is the presence of a large pool of patients suffering from diabetes and the increased need to serve them the best diabetes care and treatment.
The rising geriatric population, sedentary lifestyles, unhealthy diets, and increasing levels of physical inactivity are some of the factors that are likely to increase the risk of diabetes among people. Hence, this is likely to create the scope for market growth over the forecast period. Further, the government’s support to create awareness among the people regarding diabetes treatment and care is likely to accelerate the growth of the market over the forecast period.
In addition, a majority of countries in the region have implemented a national plan which includes diabetes individually or within a plan for non-communicable diseases (NCDs). The rising healthcare expenditure regarding the awareness, diagnosis, and treatment of diabetes is also contributing to the market growth. The European region approximately spends 9% of the total global healthcare expenditure and the expenditure on diabetes largely varies among European countries. Hence, this is likely to support the growth of the market over the forecast period.
To Request a Sample of our Report on Europe Diabetes Care Drugs Market: https://www.omrglobal.com/request-sample/europe-diabetes-care-drugs-market
Market Coverage
- Market number available for – 2022-2030
- Base year- 2022
- Forecast period- 2023-2030
- Segment Covered- By Drug Class
- Region Covered- Europe
- Competitive Landscape– Bayer AG, Boehringer Ingelheim International GmbH, Eli Lilly and Co., Johnson & Johnson Services Inc., Novartis International AG, Novo Nordisk A/S, and Sanofi SA
Europe Diabetes Care Drugs Market – Segmentation
By Drug Class
- Insulins
- Non-Insulin Injectable Drugs
- Oral Anti-Diabetic Drugs
- Combination Drugs
A full Report of Europe Diabetes Care Drugs Market is Available at: https://www.omrglobal.com/industry-reports/europe-diabetes-care-drugs-market
Europe Diabetes Care Drugs Market – Countries Covered
- Europe
- UK
- Germany
- France
- Italy
- Spain
- Rest of Europe
Company Profiles
- AstraZeneca Plc
- Bayer AG
- Boehringer Ingelheim International GmbH
- Eli Lilly and Co.
- Johnson & Johnson Services Inc.
- Mylan NV
- Novartis International AG
- Novo Nordisk A/S
- Pfizer Inc.
- Sanofi SA
Reasons to buy from us –
- We cover more than 15 major industries, further segmented into more than 90 sectors.
- More than 120 countries are for analysis.
- Over 100+ paid data sources mined for investigation.
- Our expert research analysts answer all your questions before and after purchasing your report.
For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/europe-diabetes-care-drugs-market
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services. The company also offer Digital Marketing services through its subsidiary OMR Digital and Software development and Consulting Services through another subsidiary Encanto Technologies.
Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 7803040404
